The Blood Screening Market is poised for transformative growth, anticipated to reach USD 9.898 billion by 2035, with a staggering CAGR of 10.20% from 2024 onwards. This growth is not merely a number; it signifies a crucial evolution in how healthcare providers manage blood testing. As the market continues to expand, understanding the distribution channels within the Blood Screening Market...

The global blood screening market is expanding steadily, driven by increasing blood donations, rising awareness of transfusion-transmitted infections, and stringent regulations governing blood safety. Blood screening plays a critical role in identifying infectious agents and reducing the risk of disease transmission through transfusions. Growing demand for safe blood products, improvements in...

The Blood Screening Market growth is witnessing an era of strategic alliances and technological breakthroughs designed to enhance the safety of transfusions. As global disease landscapes change, the ability to rapidly deploy new testing solutions is becoming a key differentiator for industry players. The market is increasingly characterized by companies that invest heavily in the research of...

Market Overview & Size The global blood transfusion diagnostics market stood at USD 4.4 billion in 2022, moved to an estimated USD 4.7 billion in 2023, and is projected to reach USD 6.96 billion by 2030, expanding at a CAGR of 5.8% from 2023 to 2030, according to Grand View Research. What makes this market worth watching isn't just the topline number — it's the shape of the curve. A...